GL1X · GenesisL1 explorer

MolNFT v1 · #84712 · protein

Small molecule inhibitors of the ledgf site of HIV type 1 integrase identified by fragment screening and structure based drug design

3ZT1: “Small molecule inhibitors of the ledgf site of HIV type 1 integrase identified by fragment screening and…”. X-ray diffraction, 2 ligands (OM1, SO4), 7 pockets (best druggability 0.65). MolNFT v1 #84712 on GenesisL1: 3D structure…

PDB
3ZT1
Type
protein
Length
298 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
EC
2.7.7.-
UniProt
Q76353
Ligands
OM1, SO4
Pockets
7 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BIntegrase (EC 2.7.7.-)protein14953% helix, 21% strandQ76353

Ligands and binding sites

  • OM1 · (4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]azanium · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 7 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, B
  • ACT · Acetate ion · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12490.650.8229SO4, ACT
2920.510.8321empty
31170.510.8125empty
41700.450.7532empty
51640.440.7535empty

Interfaces

1 interface between chains.

  • A–B · 1501 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 3ZT1 · Small molecule inhibitors of the LEDGF site of HIV type 1 integrase identified by… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.